Clinical Lymphoma, Myeloma & Leukemia · Nov 2026

The Association of Allostatic Load with MGUS Incidence and Risk for Progression to Multiple Myeloma

By Fiala MA, Tan Q, Wang M et al.

Background Allostatic load (AL), a theoretical construct representing the physiological "wear and tear" from chronic stress, has been associated with monoclonal gammopathy of undetermined significance (MGUS), the precursor to multiple myeloma (MM), in cross-sectional studies. This longitudinal study assessed AL’s relationship with diagnosis of incident MGUS and subsequent progression to MM. Methods A retrospective study was conducted using Veterans Health Administration data (2003–2024). AL was calculated using a 6-biomarker index: body mass index, alkaline phosphatase, albumin, creatinine, creatinine clearance, and white blood cell count. Fine and Gray subdistribution hazard models assessed the risk of incident MGUS (17,527 MGUS cases and 17,527 matched controls) and progression to MM (39,662 incident MGUS cases), with death treated as a competing risk. Results Elevated AL significantly increased the risk of incident MGUS. For each 1-unit increase in AL score, risk of MGUS diagnosis increased by 13% (adjusted hazard ratio [aHR] 1.13; 95% confidence interval [CI] 1.12-1.15; P < 0.001). Conversely, higher AL was inversely associated with MM progression (aHR 0.92; 95% CI 0.89-0.95; P < 0.001). Competing mortality likely explains this paradoxical finding; elevated AL scores were associated with a 49% increased risk of non-myeloma mortality. Overall, 7.7% of MGUS patients developed MM, whereas 45.8% of patients died before progression. Conclusions Elevated AL is associated with incident MGUS risk, supporting a link between physiological stress and plasma cell disorder development. In established MGUS, elevated non-myeloma mortality likely obscures any relationship between AL and MM progression.

doi.org/10.1016/j.clml.2026.11.003Populations

AgingResearch.News